<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-118309</identifier>
<setSpec>0009-739X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Sentinel lymph node in pulmonary carcinoma. Molecular study after radioisotope detection</dc:title>
<dc:description xml:lang="en">Introduction Metastatic lymph node affectation is the main prognostic factor in localized lung cancer. Pathological study of the obtained samples even after an adequate lymphadenectomy, present tumoral relapses of 40% of stage I patients after oncological curative surgery. In this paper we have studied micrometastasis in the sentinel lymph node by molecular methods in patients with stage I lung cancer. Material and methods The sentinel node was marked by injecting peritumorally performed just after performing the thoracotomy with 2 mCi of nanocoloid of albumin (Nanocol®) marked with 99mTc in 0.3 ml. Guided with a Navigator® gammagraphic sensor, we proceeded to its resection. RNA of the tissue was extracted and the presence of genes CEACAM5, PLUNC and CK7 in mRNA was studied. Results Twenty nine 29 patients were included. Of the tested genes, CEACAM5 and PLUNC were the ones that showed a high expression in lung tissue. Of the 29 analyzed sentinel lymph nodes, 7 (24%) were positive in the molecular study. A positive sentinel lymph node was found in 4/7 adenocarcinomas and 3/12 squamous-cell tumors. Affected lymph nodes were: station 5 (1/3), station 7 (0/6), station 9 (0/1); station 10 (5/11); station 11 (1/1).Conclusions Detection of sentinel node in patients with stage i lung cancer by marking with radioisotope is a feasible technique. The application of molecular techniques shows the tumoral affectation in cases staged as stage i (AU)</dc:description>
<dc:creator>Cremades Mira, Antonio</dc:creator>
<dc:creator>Aparisi Aparisi, Francisco</dc:creator>
<dc:creator>Galbis Caravajal, José M</dc:creator>
<dc:creator>Zuñiga Cabrera, Ángel</dc:creator>
<dc:creator>Gaspar Martinez, Cristóbal</dc:creator>
<dc:creator>Gironés Sarrió, Regina</dc:creator>
<dc:creator>Tembl Ferrairó, Ana</dc:creator>
<dc:creator>Estors Guerrero, Miriam</dc:creator>
<dc:creator>Martinez Hernandez, Néstor J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción La afectación metastásica a nivel ganglionar es el principal factor pronóstico en el carcinoma pulmonar localizado. Pese al estudio anatomopatológico de las piezas obtenidas tras una adecuada linfadenectomía mediastínica, la recidiva tumoral alcanza el 40% en pacientes estadio i tras la cirugía oncológica curativa. En este trabajo hemos realizado el estudio de micrometástasis por métodos moleculares en el ganglio centinela de pacientes con carcinoma pulmonar estadio i .Material y métodos Marcaje del ganglio centinela mediante la inyección peritumoral de 2 mCi de nanocoloide de albúmina (Nanocol®) marcado con 99mTc en un volumen de 0,3 ml tras la toracotomía. Guiados mediante la sonda gammagráfica Navigator® se procedió a su localización y exéresis. Se extrajo ARN de los tejidos y se analizó la presencia de ARNm de los genes CEACAM5, PLUNC y CK7.ResultadosSe incluyó a 29 pacientes. De los genes testados, el CEACAM5 y el PLUNC fueron los que mostraron una alta expresión en tejido pulmonar. De los 29 ganglios centinela analizados, 7 (24%) fueron positivos para estudio molecular. Se encontró ganglio centinela positivo en: 4/7 adenocarcinomas y 3/12 escamosos. Los ganglios afectos fueron: nivel 5 (1/3), nivel 7 (0/6), nivel 9 (0/1), nivel 10 (5/11), nivel 11 (1/1).Conclusiones La detección del ganglio centinela en pacientes con carcinoma pulmonar estadio i mediante marcaje con radioisótopo es factible. La aplicación de técnicas moleculares pone de manifiesto la afectación tumoral en casos estadificados como estadio i  (AU)</dc:description>
<dc:source>Cir. Esp. (Ed. impr.);92(1): 11-15, ene. 2014. tab</dc:source>
<dc:identifier>ibc-118309</dc:identifier>
<dc:title xml:lang="es">El ganglio centinela en el carcinoma pulmonar. Estudio molecular tras detección con radioisótopo</dc:title>
<dc:subject>^d31722^s22053</dc:subject>
<dc:subject>^d8384^s22053</dc:subject>
<dc:subject>^d8352^s22053</dc:subject>
<dc:subject>^d35392^s22074</dc:subject>
<dc:subject>^d36304^s22074</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d12306</dc:subject>
<dc:type>article</dc:type>
<dc:date>201401</dc:date>
</metadata>
</record>
</ibecs-document>
